United States Chromosomal Abnormality Market Report 2016

Publisher Name :
Date: 13-Sep-2016
No. of pages: 115
Inquire Before Buying

Notes:

Sales, means the sales volume of Chromosomal Abnormality

Revenue, means the sales value of Chromosomal Abnormality

This report studies sales (consumption) of Chromosomal Abnormality in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Abbott Molecular Inc. (US)

- Life Technologies Corporation (US)

- Affymetrix, Inc. (US)

- PerkinElmer, Inc. (US)

- Bluegnome, ltd. (UK)

- Applied Spectral Imaging (US)

- SciGene Corporation (US)

- BI Biological Industries (Israel)

- ChromTrax (US)

- CytoTest, Inc. (UK)

- Cytognomix, Inc. (Canada)

- Illumina, Inc. (US)

- Inter Medico (Canada)

- Kreatech Diagnostics (The Netherlands)

- Oxford Gene Technology (UK)

- Roche NimbleGen, Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Chromosomal Abnormality in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Chromosomal Abnormality Market Report 2016

Table of Contents
United States Chromosomal Abnormality Market Report 2016
1 Chromosomal Abnormality Overview
1.1 Product Overview and Scope of Chromosomal Abnormality
1.2 Classification of Chromosomal Abnormality
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Chromosomal Abnormality
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Chromosomal Abnormality (2011-2021)
1.4.1 United States Chromosomal Abnormality Sales and Growth Rate (2011-2021)
1.4.2 United States Chromosomal Abnormality Revenue and Growth Rate (2011-2021)
2 United States Chromosomal Abnormality Competition by Manufacturers
2.1 United States Chromosomal Abnormality Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Chromosomal Abnormality Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Chromosomal Abnormality Average Price by Manufactures (2015 and 2016)
2.4 Chromosomal Abnormality Market Competitive Situation and Trends
2.4.1 Chromosomal Abnormality Market Concentration Rate
2.4.2 Chromosomal Abnormality Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Chromosomal Abnormality Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Chromosomal Abnormality Sales and Market Share by Type (2011-2016)
3.2 United States Chromosomal Abnormality Revenue and Market Share by Type (2011-2016)
3.3 United States Chromosomal Abnormality Price by Type (2011-2016)
3.4 United States Chromosomal Abnormality Sales Growth Rate by Type (2011-2016)
4 United States Chromosomal Abnormality Sales (Volume) by Application (2011-2016)
4.1 United States Chromosomal Abnormality Sales and Market Share by Application (2011-2016)
4.2 United States Chromosomal Abnormality Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Chromosomal Abnormality Manufacturers Profiles/Analysis
5.1 Abbott Molecular Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Chromosomal Abnormality Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Abbott Molecular Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Life Technologies Corporation (US)
5.2.2 Chromosomal Abnormality Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Life Technologies Corporation (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Affymetrix, Inc. (US)
5.3.2 Chromosomal Abnormality Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Affymetrix, Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 PerkinElmer, Inc. (US)
5.4.2 Chromosomal Abnormality Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 PerkinElmer, Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Bluegnome, ltd. (UK)
5.5.2 Chromosomal Abnormality Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Bluegnome, ltd. (UK) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Applied Spectral Imaging (US)
5.6.2 Chromosomal Abnormality Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Applied Spectral Imaging (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 SciGene Corporation (US)
5.7.2 Chromosomal Abnormality Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 SciGene Corporation (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 BI Biological Industries (Israel)
5.8.2 Chromosomal Abnormality Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 BI Biological Industries (Israel) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 ChromTrax (US)
5.9.2 Chromosomal Abnormality Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 ChromTrax (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 CytoTest, Inc. (UK)
5.10.2 Chromosomal Abnormality Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 CytoTest, Inc. (UK) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Cytognomix, Inc. (Canada)
5.12 Illumina, Inc. (US)
5.13 Inter Medico (Canada)
5.14 Kreatech Diagnostics (The Netherlands)
5.15 Oxford Gene Technology (UK)
5.16 Roche NimbleGen, Inc. (US)
6 Chromosomal Abnormality Manufacturing Cost Analysis
6.1 Chromosomal Abnormality Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Chromosomal Abnormality
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Chromosomal Abnormality Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Chromosomal Abnormality Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Chromosomal Abnormality Market Forecast (2016-2021)
10.1 United States Chromosomal Abnormality Sales, Revenue Forecast (2016-2021)
10.2 United States Chromosomal Abnormality Sales Forecast by Type (2016-2021)
10.3 United States Chromosomal Abnormality Sales Forecast by Application (2016-2021)
10.4 Chromosomal Abnormality Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Chromosomal Abnormality
Table Classification of Chromosomal Abnormality
Figure United States Sales Market Share of Chromosomal Abnormality by Type in 2015
Table Application of Chromosomal Abnormality
Figure United States Sales Market Share of Chromosomal Abnormality by Application in 2015
Figure United States Chromosomal Abnormality Sales and Growth Rate (2011-2021)
Figure United States Chromosomal Abnormality Revenue and Growth Rate (2011-2021)
Table United States Chromosomal Abnormality Sales of Key Manufacturers (2015 and 2016)
Table United States Chromosomal Abnormality Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Chromosomal Abnormality Sales Share by Manufacturers
Figure 2016 Chromosomal Abnormality Sales Share by Manufacturers
Table United States Chromosomal Abnormality Revenue by Manufacturers (2015 and 2016)
Table United States Chromosomal Abnormality Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Chromosomal Abnormality Revenue Share by Manufacturers
Table 2016 United States Chromosomal Abnormality Revenue Share by Manufacturers
Table United States Market Chromosomal Abnormality Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Chromosomal Abnormality Average Price of Key Manufacturers in 2015
Figure Chromosomal Abnormality Market Share of Top 3 Manufacturers
Figure Chromosomal Abnormality Market Share of Top 5 Manufacturers
Table United States Chromosomal Abnormality Sales by Type (2011-2016)
Table United States Chromosomal Abnormality Sales Share by Type (2011-2016)
Figure United States Chromosomal Abnormality Sales Market Share by Type in 2015
Table United States Chromosomal Abnormality Revenue and Market Share by Type (2011-2016)
Table United States Chromosomal Abnormality Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Chromosomal Abnormality by Type (2011-2016)
Table United States Chromosomal Abnormality Price by Type (2011-2016)
Figure United States Chromosomal Abnormality Sales Growth Rate by Type (2011-2016)
Table United States Chromosomal Abnormality Sales by Application (2011-2016)
Table United States Chromosomal Abnormality Sales Market Share by Application (2011-2016)
Figure United States Chromosomal Abnormality Sales Market Share by Application in 2015
Table United States Chromosomal Abnormality Sales Growth Rate by Application (2011-2016)
Figure United States Chromosomal Abnormality Sales Growth Rate by Application (2011-2016)
Table Abbott Molecular Inc. (US) Basic Information List
Table Abbott Molecular Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Molecular Inc. (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Life Technologies Corporation (US) Basic Information List
Table Life Technologies Corporation (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Life Technologies Corporation (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Affymetrix, Inc. (US) Basic Information List
Table Affymetrix, Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Affymetrix, Inc. (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table PerkinElmer, Inc. (US) Basic Information List
Table PerkinElmer, Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table PerkinElmer, Inc. (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Bluegnome, ltd. (UK) Basic Information List
Table Bluegnome, ltd. (UK) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bluegnome, ltd. (UK) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Applied Spectral Imaging (US) Basic Information List
Table Applied Spectral Imaging (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Applied Spectral Imaging (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table SciGene Corporation (US) Basic Information List
Table SciGene Corporation (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table SciGene Corporation (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table BI Biological Industries (Israel) Basic Information List
Table BI Biological Industries (Israel) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table BI Biological Industries (Israel) Chromosomal Abnormality Sales Market Share (2011-2016)
Table ChromTrax (US) Basic Information List
Table ChromTrax (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table ChromTrax (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table CytoTest, Inc. (UK) Basic Information List
Table CytoTest, Inc. (UK) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table CytoTest, Inc. (UK) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Cytognomix, Inc. (Canada) Basic Information List
Table Cytognomix, Inc. (Canada) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cytognomix, Inc. (Canada) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Illumina, Inc. (US) Basic Information List
Table Illumina, Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina, Inc. (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Inter Medico (Canada) Basic Information List
Table Inter Medico (Canada) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Inter Medico (Canada) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Kreatech Diagnostics (The Netherlands) Basic Information List
Table Kreatech Diagnostics (The Netherlands) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kreatech Diagnostics (The Netherlands) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Oxford Gene Technology (UK) Basic Information List
Table Oxford Gene Technology (UK) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oxford Gene Technology (UK) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Roche NimbleGen, Inc. (US) Basic Information List
Table Roche NimbleGen, Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche NimbleGen, Inc. (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chromosomal Abnormality
Figure Manufacturing Process Analysis of Chromosomal Abnormality
Figure Chromosomal Abnormality Industrial Chain Analysis
Table Raw Materials Sources of Chromosomal Abnormality Major Manufacturers in 2015
Table Major Buyers of Chromosomal Abnormality
Table Distributors/Traders List
Figure United States Chromosomal Abnormality Production and Growth Rate Forecast (2016-2021)
Figure United States Chromosomal Abnormality Revenue and Growth Rate Forecast (2016-2021)
Table United States Chromosomal Abnormality Production Forecast by Type (2016-2021)
Table United States Chromosomal Abnormality Consumption Forecast by Application (2016-2021)
  • Asia-Pacific Cholesterol Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 19-Jan-2018        Price: US 4480 Onwards        Pages: 119
    Cholesterol is a kind of sterol or steroid, of which the chemical formula is C27H46O. Cholesterol is a kind of flaky crystal under solid state, white and odorless. At present, cholesterol is mainly produced with lanolin and is industrially applied as raw materials of Vitamin D3, additive to prawn feed, medicine, as well cosmetics emulsifier and etc. Cholesterol is used in pharmaceutical, cosmetic and crustacean feed applications. Scope of the Report: This report focuses on ......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Pharmaceutical Grade HPMC Market 2017 Forecast to 2022
    Published: 19-Jan-2018        Price: US 4880 Onwards        Pages: 116
    Hydroxypropyl methylcellulose (HPMC) is a semisynthetic, inert, viscoelastic polymer used as eye drops, as well as a tablet coating, adhesive and controlled-delivery component in oral medicaments, found in a variety of commercial products. Scope of the Report: This report focuses on the Pharmaceutical Grade HPMC in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufactu......
  • Global Ornithine-Transcarbamylase Deficiency Sales Market Report 2018
    Published: 18-Jan-2018        Price: US 4000 Onwards        Pages: 106
    In this report, the global Ornithine-Transcarbamylase Deficiency market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Ornithine-Transcarbamylase Deficiency for these regions, from 2013 to 2025 (forecast), covering - United States -......
  • Global Pancreatic Endocrine Tumor Drug Sales Market Report 2018
    Published: 18-Jan-2018        Price: US 4000 Onwards        Pages: 104
    In this report, the global Pancreatic Endocrine Tumor Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Pancreatic Endocrine Tumor Drug for these regions, from 2013 to 2025 (forecast), covering - United States - China......
  • Global Deep Sea Fish oil Softgel Market Research Report 2018
    Published: 18-Jan-2018        Price: US 2900 Onwards        Pages: 113
    In this report, the global Deep Sea Fish oil Softgel market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Deep Sea Fish oil Softgel in these regions, from 2013 to 2025 (forecast), covering - North America - Europe ......
  • Global Pharmaceutical Chemicals Sales Market Report 2018
    Published: 18-Jan-2018        Price: US 4000 Onwards        Pages: 104
    In this report, the global Pharmaceutical Chemicals market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Pharmaceutical Chemicals for these regions, from 2013 to 2025 (forecast), covering - United States - China - Europe......
  • Global Phenylketonuria Drug Sales Market Report 2018
    Published: 18-Jan-2018        Price: US 4000 Onwards        Pages: 105
    In this report, the global Phenylketonuria Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Phenylketonuria Drug for these regions, from 2013 to 2025 (forecast), covering - United States - China - Europe - Ja......
  • Global Green Coffee Extract Market Research Report 2018
    Published: 18-Jan-2018        Price: US 2900 Onwards        Pages: 114
    In this report, the global Green Coffee Extract market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Green Coffee Extract in these regions, from 2013 to 2025 (forecast), covering - North America - Europe - China......
  • Global Propolis Sales Market Report 2018
    Published: 18-Jan-2018        Price: US 4000 Onwards        Pages: 124
    In this report, the global Propolis market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Propolis for these regions, from 2013 to 2025 (forecast), covering - United States - China - Europe - Japan - Southeast As......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs